In Vitro Stem Cell Hemotoxicity Testing
HemoGenix® was the first to develop and commercialize assay platforms to specifically detect and predict hemotoxicity for drug discovery and development and environmental testing.
At HemoGenix®, we specialize in in vitro stem cell hemotoxicity testing and have developed a number of validated assays that can predict various aspects of toxicity to the blood-forming system. We provide both a Full Contract Service and an extensive Assay Kit Product Line for this purpose.
The in vitro platform capable of providing you with this information is called HALO® or Hematopoietic / Hemotoxicity Assay via Luminescence Output. The following pages describe various applications of the HALO® Hemotoxicity Platform and more information about the HALO® Platform itself can be found in the PLATFORM Section of our website.
HemoGenix® is the Industry Leader in Predictive In Vitro Stem Cell Hemotoxicity Testing
